Pharmaceutical sanctioned with US $ 9,000 million per diabetes medicine

  
fer
04/28/2014 6:06 a.m.

The billionaire figure was imposed on the multinational Takeda and its partner Eli Lilly for hiding the health risks generated by 'acts'.

Take that Takeda Pharmaceuticals and Eli Lilly, their partner in the United States, hide the risks of contract, US $ 9,000 million.

Takeda, the largest pharmaceutical of Asia and whose headquarters is in Tokyo, Japan, will be responsible for paying US $ 6,000 million.

The sanction is one of the highest imposed on a multinational and opens the doors so that, after this trial, hundreds of similar cases began to appear after 1999, when the drug entered the American market.

Shortly after having done it, acts, which turned out to be one of the best options to treat type 2 diabetes, became one of the most popular of the Japanese company.Even in 2008, its best year in sales, managed to raise US $ 3,850 million in the world.

It is estimated that, throughout this decade it could have generated income for US $ 16,000 million.

But it was enough for a couple more years to start associating with health problems.In fact, this trial in Lafayette, which lasted about two months, was the fourth that was held in the US.

And although the payment of the Japanese company to the 2,700 plaintiffs will not yet be certain, it is expected to begin to advance similar processes in Nevada and Illinois.

Already on another occasion the same jury had granted US $ 1.5 billion in compensatory damages to Terrence Allen, who because of the medicine developed bladder cancer.

However, the pharmaceutical directives rejected the decision.In a statement they said that they will resort to all legal means to deal with the fine.They also said that they are able to demonstrate that they acted in responsibility by informing the public about the risks associated with acts, a medicine that two years ago had been suspended in France and Germany.

And despite the fact that the measure is historical for being one of the highest imposed on a pharmacist, the United States Supreme Court may reduce the amount significantly as has happened with other companies.

A sanction of US $ 5,000 against Exxonmobil, for example, was at US $ 500 million.

However, the results of the ruling have already begun to be seen: Takeda lost 5% its stock market capitalization in the Tokyo market, while Eli Lilly, in charge of marketing acts in the US, Mexico and Canada, had stumbling blocks in the day in the day in the day inWall Street.

Diabetes Tipo 1 desde 1.998 | FreeStyle Libre 3 | Ypsomed mylife YpsoPump + CamAPS FX | Sin complicaciones. Miembro del equipo de moderación del foro.

Autor de Vivir con Diabetes: El poder de la comunidad online, parte de los ingresos se destinan a financiar el foro de diabetes y mantener la comunidad online activa.

  
Garci
07/16/2017 4:39 p.m.

Q well Lilly is the pharmacist of India who puts on my son in the end .....

No signature configured, add it on your user's profile.

Join the Discussion!

To participate in this thread, please register or log in.

 

Support the Community: Buy "Living with Diabetes: The Power of the Online Community" 💙

Did you know that the forum operates without ads thanks to the book's revenue?
Each purchase helps us continue providing a space for support, learning, and connection for thousands of people with diabetes.

Why buy it?

You help keep this forum alive, a free and accessible community for everyone. You'll discover stories, advice, and experiences that transform the lives of those facing diabetes. With your support, we will continue sharing valuable information and resources for people with diabetes and their families.

💡 Every book counts. It's more than a purchase—it's an act of support that makes a difference.

👉 Buy the book now and be part of something great.

Thank you for being part of our community and for your constant support! 💙

 

See the book at